NASDAQ

BriaCell Therapeutics Corp. - Common Shares (BCTX)

356 Thanks from members

BriaCell Therapeutics Corp. (BCTX) displays high volatility and retail-driven enthusiasm fueled by clinical milestones like lung metastasis resolution, tempered by growing net losses, substantial going concern warnings, and dilutive public unit offerings.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →